Paper · 14517244
Activated EGL-15 FGF receptor promotes protein degradation in muscles of Caenorhabditis elegans.
Szewczyk NJ and 1 other. EMBO J, 2003. Cited by 26 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Activated EGL-15 FGF receptor promotes protein degradation in muscles of Caenorhabditis elegans. Papers, record 14517244. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14517244
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Caenorhabditis elegans | Major topic |
| Caenorhabditis elegans Proteins | Major topic |
| Muscle Proteins | Major topic |
| Receptors, Fibroblast Growth Factor | Major topic |
| Animals | |
| Mitogen-Activated Protein Kinases | |
| Muscles | |
| Signal Transduction | |
| ras Proteins |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,806,111 | Genetic defects in acetylcholine signalling promote protein degradation in muscle cells of Caenorhabditis elegans. | J Cell Sci | 2000 | https://conductscience.org/library/papers/10806111 | PubMed |
| 2 | 12,024,031 | Activation of Ras and the mitogen-activated protein kinase pathway promotes protein degradation in muscle cells of Caenorhabditis elegans. | Mol Cell Biol | 2002 | https://conductscience.org/library/papers/12024031 | PubMed |
| 3 | 10,880,441 | Caenorhabditis elegans SOS-1 is necessary for multiple RAS-mediated developmental signals. | EMBO J | 2000 | https://conductscience.org/library/papers/10880441 | PubMed |
| 4 | 10,898,801 | Gene expression patterns of the fibroblast growth factors and their receptors during myogenesis of rat satellite cells. | J Histochem Cytochem | 2000 | https://conductscience.org/library/papers/10898801 | PubMed |
| 5 | 11,021,802 | Regulation of C. elegans life-span by insulinlike signaling in the nervous system. | Science | 2000 | https://conductscience.org/library/papers/11021802 | PubMed |
| 6 | 11,181,961 | Cytoplasmic signaling pathways that regulate cardiac hypertrophy. | Annu Rev Physiol | 2001 | https://conductscience.org/library/papers/11181961 | PubMed |
| 7 | 14,630,038 | Degradation of transgene-coded and endogenous proteins in the muscles of Caenorhabditis elegans. | Biochem Biophys Res Commun | 2003 | https://conductscience.org/library/papers/14630038 | PubMed |
| 8 | 3,316,916 | Protein degradation during endurance exercise and recovery. | Med Sci Sports Exerc | 1987 | https://conductscience.org/library/papers/3316916 | PubMed |
| 9 | 2,843,547 | Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. | J Cell Biol | 1988 | https://conductscience.org/library/papers/2843547 | PubMed |
| 10 | 2,569,235 | Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. | Science | 1989 | https://conductscience.org/library/papers/2569235 | PubMed |
1 to 10 of 60
See all 60 referencesCited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,849,383 | The conserved fibroblast growth factor receptor-based signaling is required for dendrite regeneration. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41849383 | PubMed |
| 33,338,030 | FGF23 signalling and physiology. | J Mol Endocrinol | 2021 | https://conductscience.org/library/papers/33338030 | PubMed |
| 30,782,598 | A Receptor Tyrosine Kinase Network Regulates Neuromuscular Function in Response to Oxidative Stress in Caenorhabditis elegans. | Genetics | 2019 | https://conductscience.org/library/papers/30782598 | PubMed |
| 30,455,409 | Greater loss of mitochondrial function with ageing is associated with earlier onset of sarcopenia in C. elegans. | Aging (Albany NY) | 2018 | https://conductscience.org/library/papers/30455409 | PubMed |
| 28,536,403 | Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes. | Biomedicines | 2015 | https://conductscience.org/library/papers/28536403 | PubMed |
| 28,508,547 | Functional phosphatome requirement for protein homeostasis, networked mitochondria, and sarcomere structure in C. elegans muscle. | J Cachexia Sarcopenia Muscle | 2017 | https://conductscience.org/library/papers/28508547 | PubMed |
| 24,285,704 | Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation. | Biol Open | 2013 | https://conductscience.org/library/papers/24285704 | PubMed |
| 24,060,339 | Knockdown of the C. elegans kinome identifies kinases required for normal protein homeostasis, mitochondrial network structure, and sarcomere structure in muscle. | Cell Commun Signal | 2013 | https://conductscience.org/library/papers/24060339 | PubMed |
| 23,908,058 | Canonical RTK-Ras-ERK signaling and related alternative pathways. | WormBook | 2013 | https://conductscience.org/library/papers/23908058 | PubMed |
| 23,900,546 | The NM23-H1/H2 homolog NDK-1 is required for full activation of Ras signaling in C. elegans. | Development | 2013 | https://conductscience.org/library/papers/23900546 | PubMed |
1 to 10 of 20
See all 20 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14517244
GET https://conductscience.org/api/papers/v1/14517244/references?page=2